E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/5/2014 in the Prospect News Structured Products Daily.

New Issue: HSBC prices $1.08 million dual directional contingent buffered enhanced notes on Pfizer

By Toni Weeks

San Luis Obispo, Calif., Aug. 5 – HSBC USA Inc. priced $1.08 million of 0% dual directional contingent buffered enhanced notes due Aug. 20, 2015 linked to the common stock of Pfizer Inc., according to a 424B2 filing with the Securities and Exchange Commission.

If the share return is greater than 5%, the payout at maturity will be par plus the return, capped at 12%.

If the share return is greater than or equal to negative 5% but less than or equal to 5%, the payout at maturity will be par plus the contingent minimum return of 5%.

If the final share price is less than negative 5% but equal to or greater than negative 10%, the payout will be par plus the absolute value of the stock return.

If the final share price is less than the initial share price by more than 10%, investors will lose 1% for every 1% that the final share price is less than the initial share price.

The final share price will be the average of the closing prices on the five trading days ending Aug. 17, 2015.

HSBC Securities (USA) Inc. is the underwriter. J.P. Morgan Securities LLC is the placement agent.

Issuer:HSBC USA Inc.
Issue:Dual directional contingent buffered enhanced notes
Underlying stock:Pfizer Inc. (Symbol: PFE)
Amount:$1.08 million
Maturity:Aug. 20, 2015
Coupon:0%
Price:Par
Payout at maturity:If the stock return is greater than 5%, par plus the return, capped at 12%; if return is greater than or equal to negative 5% but less than or equal to 5%, par plus 5%; if final price is less than negative 5% but equal to or greater than negative 10%, par plus absolute value of the stock return; if final price is less than initial price by more than 10%, full exposure to losses from initial price
Initial price:$28.86
Pricing date:Aug. 1
Settlement date:Aug. 6
Underwriter:HSBC Securities (USA) Inc.
Agent:J.P. Morgan Securities LLC
Fees:1%
Cusip:40433BKV9

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.